Cargando…

Dingkun pill alleviates metabolic abnormalities in polycystic ovary syndrome through brown adipose tissue activation

BACKGROUND: Traditional Chinese medicine has been used for a long time to treat a variety of gynecological diseases. Among various traditional Chinese medicine, Dingkun Pill (DK) has been used for the treatment of female gynecological diseases. However, DK therapeutic effect on PCOS and the target t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Mengqing, Cai, Han, Deng, Weinan, Tang, Yedong, Du, Shuailin, Wang, Peiran, Deng, Wenbo, Wang, Haibin, Sun, Aijun, Kong, Shuangbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463533/ https://www.ncbi.nlm.nih.gov/pubmed/37633943 http://dx.doi.org/10.1186/s13048-023-01215-0

Ejemplares similares

The Efficacy and Safety of Dingkun Pill in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Jin, Bao, et al.
Publicado: (2022)

Traditional Chinese medicine Dingkun pill to increase fertility in women with a thin endometrium—a prospective randomized study
por: Jin, Fengyu, et al.
Publicado: (2023)

P38α MAPK is a gatekeeper of uterine progesterone responsiveness at peri-implantation via Ube3c-mediated PGR degradation
por: Tang, Yedong, et al.
Publicado: (2022)

Brown Adipose Transplantation Improves Polycystic Ovary Syndrome-Involved Metabolome Remodeling
por: Yao, Lihua, et al.
Publicado: (2021)

Brown Adipose Tissue and Novel Management Strategies for Polycystic Ovary Syndrome Therapy
por: Zhang, Qiaoli, et al.
Publicado: (2022)

Efficacy and safety of Dingkun pill for female infertility patients with low prognosis undergoing in vitro fertilization-embryo transfer: study protocol for a multicenter, double-blind, randomized, placebo-controlled trial
por: Song, Jingyan, et al.
Publicado: (2020)

Brown Adipose Tissue Activation by Cold Treatment Ameliorates Polycystic Ovary Syndrome in Rat
por: Ye, Rongcai, et al.
Publicado: (2021)

Metabolic abnormalities in adolescents with polycystic ovary syndrome in south china
por: Huang, Jia, et al.
Publicado: (2010)

Abnormal Endometrial Receptivity and Oxidative Stress in Polycystic Ovary Syndrome
por: Shan, Hongying, et al.
Publicado: (2022)

The role of the thyroid in polycystic ovary syndrome
por: Fan, Huanhuan, et al.
Publicado: (2023)

Enoxacin ameliorates polycystic ovary syndrome by promoting the browning of white adipose tissue and restoring gut dysbiosis
por: Zhu, Wanlong, et al.
Publicado: (2022)

Estrogen Receptors in Polycystic Ovary Syndrome
por: Xu, Xue-Ling, et al.
Publicado: (2021)

Inhibition of sestrin 1 alleviates polycystic ovary syndrome by decreasing autophagy
por: Xu, Xiaoyuan, et al.
Publicado: (2021)

First intention IVF protocol for polycystic ovaries: does oral contraceptive pill pretreatment influence COH outcome?
por: Decanter, Christine, et al.
Publicado: (2013)

Investigation of the Mechanism of Zishen Yutai Pills on Polycystic Ovary Syndrome: A Network Pharmacology and Molecular Docking Approach
por: Chen, Yingyin, et al.
Publicado: (2021)

The serum level of irisin, but not asprosin, is abnormal in polycystic ovary syndrome patients
por: Chang, Chia Lin, et al.
Publicado: (2019)

Research Progress on the Mechanism Between Polycystic Ovary Syndrome and Abnormal Endometrium
por: Xue, Zhu, et al.
Publicado: (2021)

Abnormal Activation of Tryptophan-Kynurenine Pathway in Women With Polycystic Ovary Syndrome
por: Wang, Siyu, et al.
Publicado: (2022)

Is polycystic ovary syndrome appropriately diagnosed by obstetricians and gynaecologists across China: a nationwide survey
por: Yan, Deng, et al.
Publicado: (2021)

The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: A protocol for systematic review and meta-analysis
por: Ma, Ruilin, et al.
Publicado: (2021)

Does endothelial dysfunction correlate with endocrinal abnormalities in patients with polycystic ovary syndrome?
por: Dube, Rajani
Publicado: (2016)

Does polycystic ovary syndrome affect morphokinetics or abnormalities in early embryonic development?()
por: Tam Le, Minh, et al.
Publicado: (2019)

Adrenal Androgen Predictive Effects on Clinical and Metabolic Abnormalities of Polycystic Ovary Syndrome
por: Medeiros, Sebastião Freitas de, et al.
Publicado: (2022)

Polycystic Ovary Syndrome
por: Franks, Stephen
Publicado: (1998)

MicroRNA-21 Modulates White Adipose Tissue Browning and Altered Thermogenesis in a Mouse Model of Polycystic Ovary Syndrome
por: Rezq, Samar, et al.
Publicado: (2021)

Serum metabolomic profiling reveals potential biomarkers in assessing the management of women with polycystic ovary syndrome: a randomized controlled trial
por: Ding, Xuesong, et al.
Publicado: (2022)

Sequential activation of uterine epithelial IGF1R by stromal IGF1 and embryonic IGF2 directs normal uterine preparation for embryo implantation
por: Zhou, Chan, et al.
Publicado: (2021)

Mst1-mediated phosphorylation of Nur77 improves the endometrial receptivity in human and mice
por: Cai, Xinyu, et al.
Publicado: (2023)

Growth hormone alleviates oxidative stress and improves oocyte quality in Chinese women with polycystic ovary syndrome: a randomized controlled trial
por: Gong, Yan, et al.
Publicado: (2020)

Obesity management in polycystic ovary syndrome: disparity in knowledge between obstetrician-gynecologists and reproductive endocrinologists in China
por: Ma, Ruilin, et al.
Publicado: (2021)

Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis
por: Yang, Rui, et al.
Publicado: (2016)

Multiomics Analysis Reveals Molecular Abnormalities in Granulosa Cells of Women With Polycystic Ovary Syndrome
por: Zhao, Rusong, et al.
Publicado: (2021)

Analysis of Methylome, Transcriptome, and Lipid Metabolites to Understand the Molecular Abnormalities in Polycystic Ovary Syndrome
por: Zhang, Fei, et al.
Publicado: (2023)

Triglyceride and glucose index for identifying abnormal insulin sensitivity in women with polycystic ovary syndrome
por: Kwon, Seeun, et al.
Publicado: (2023)

Effects of TCM on polycystic ovary syndrome and its cellular endocrine mechanism
por: Chen, Huize, et al.
Publicado: (2023)

Mediators of Inflammation in Polycystic Ovary Syndrome in Relation to Adiposity
por: Sathyapalan, Thozhukat, et al.
Publicado: (2010)

The effects of exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: protocol for a systematic review and meta-analysis
por: Woodward, Amie, et al.
Publicado: (2019)

The effects of physical exercise on cardiometabolic outcomes in women with polycystic ovary syndrome not taking the oral contraceptive pill: a systematic review and meta-analysis
por: Woodward, Amie, et al.
Publicado: (2019)

Pregnancy in polycystic ovary syndrome
por: Kamalanathan, Sadishkumar, et al.
Publicado: (2013)

The inositols and polycystic ovary syndrome
por: Kalra, Bharti, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6gk5heurbrkdtfptt1ikb3if2u